New hope for tough bladder cancers: trial tests promising drug combo

NCT ID NCT07129993

Recruiting now Disease control Sponsor: Daiichi Sankyo Source: ClinicalTrials.gov ↗

Summary

This study is for people with advanced bladder cancer that has continued to grow despite receiving a specific prior combination treatment. It will compare a new drug combination (datopotamab deruxtecan plus a platinum chemotherapy) against a standard chemotherapy combination. The goal is to see if the new combination can better control the cancer, help patients live longer, and is safe for 630 participants worldwide.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
ACTIVE_NOT_RECRUITING

Fullerton, California, 92835, United States
Research Site
ACTIVE_NOT_RECRUITING

La Jolla, California, 92093, United States
Research Site
ACTIVE_NOT_RECRUITING

San Francisco, California, 94158, United States
Research Site
ACTIVE_NOT_RECRUITING

Aurora, Colorado, 80012, United States
Research Site
ACTIVE_NOT_RECRUITING

Orange City, Florida, 32763, United States
Research Site
ACTIVE_NOT_RECRUITING

St. Petersburg, Florida, 33701, United States
Research Site
ACTIVE_NOT_RECRUITING

Tamarac, Florida, 62269, United States
Research Site
ACTIVE_NOT_RECRUITING

Atlanta, Georgia, 30342, United States
Research Site
ACTIVE_NOT_RECRUITING

Locust Grove, Georgia, 30248, United States
Research Site
ACTIVE_NOT_RECRUITING

Effingham, Illinois, 62401, United States
Research Site
RECRUITING

Niles, Illinois, 60714, United States
Research Site
RECRUITING

Peoria, Illinois, 61615, United States
Research Site
ACTIVE_NOT_RECRUITING

Largo, Maryland, 20774, United States
Research Site
RECRUITING

Grand Rapids, Michigan, 49546, United States
Research Site
ACTIVE_NOT_RECRUITING

St Louis, Missouri, 63110, United States
Research Site
ACTIVE_NOT_RECRUITING

New York, New York, 10029, United States
Research Site
ACTIVE_NOT_RECRUITING

Raleigh, North Carolina, 27610, United States
Research Site
ACTIVE_NOT_RECRUITING

Portland, Oregon, 97227, United States
Research Site
ACTIVE_NOT_RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Research Site
ACTIVE_NOT_RECRUITING

Myrtle Beach, South Carolina, 29572, United States
Research Site
ACTIVE_NOT_RECRUITING

Germantown, Tennessee, 38138, United States
Research Site
RECRUITING

Nashville, Tennessee, 37203, United States
Research Site
ACTIVE_NOT_RECRUITING

Austin, Texas, 33322, United States
Research Site
ACTIVE_NOT_RECRUITING

Dallas, Texas, 75246, United States
Research Site
ACTIVE_NOT_RECRUITING

Dallas, Texas, 75390, United States
Research Site
ACTIVE_NOT_RECRUITING

Charlottesville, Virginia, 22908, United States
Research Site
ACTIVE_NOT_RECRUITING

Norfolk, Virginia, 23502-1871, United States
Research Site
ACTIVE_NOT_RECRUITING

Spokane, Washington, 99208, United States
Research Site
ACTIVE_NOT_RECRUITING

Madison, Wisconsin, 53715, United States
Research Site
ACTIVE_NOT_RECRUITING

Krems, Austria
Research Site
ACTIVE_NOT_RECRUITING

Vienna, Austria
Research Site
RECRUITING

Beijing, 100142, China
Research Site
ACTIVE_NOT_RECRUITING

Chengdu, China
Research Site
ACTIVE_NOT_RECRUITING

Guangzhou, China
Research Site
ACTIVE_NOT_RECRUITING

Angers, 49055, France
Research Site
RECRUITING

Bordeaux, 33075, France
Research Site
RECRUITING

Brest, France
Research Site
ACTIVE_NOT_RECRUITING

Calais, France
Research Site
RECRUITING

Cedex 10, France
Research Site
ACTIVE_NOT_RECRUITING

Créteil, France
Research Site
ACTIVE_NOT_RECRUITING

Grenoble, France
Research Site
ACTIVE_NOT_RECRUITING

La Chaussée-Saint-Victor, France
Research Site
ACTIVE_NOT_RECRUITING

La Roche-sur-Yon, France
Research Site
RECRUITING

Le Mans, France
Research Site
ACTIVE_NOT_RECRUITING

Lyon, France
Research Site
ACTIVE_NOT_RECRUITING

Marseille, France
Research Site
RECRUITING

Montpellier, France
Research Site
ACTIVE_NOT_RECRUITING

Nantes, France
Research Site
ACTIVE_NOT_RECRUITING

Nîmes, France
Research Site
ACTIVE_NOT_RECRUITING

Paris, France
Research Site
RECRUITING

Paris, France
Research Site
ACTIVE_NOT_RECRUITING

Pierre-Bénite, 69310, France
Research Site
RECRUITING

Poitiers, France
Research Site
ACTIVE_NOT_RECRUITING

Quint-Fonsegrives, France
Research Site
ACTIVE_NOT_RECRUITING

Reims, France
Research Site
RECRUITING

Saint-Etienne, France
Research Site
ACTIVE_NOT_RECRUITING

Saint-Herblain, France
Research Site
ACTIVE_NOT_RECRUITING

Toulouse, France
Research Site
ACTIVE_NOT_RECRUITING

Vandœuvre-lès-Nancy, France
Research Site
RECRUITING

Nürtingen, Germany
Research Site
ACTIVE_NOT_RECRUITING

Napoli, Italy
Research Site
ACTIVE_NOT_RECRUITING

Roma, Italy
Research Site
ACTIVE_NOT_RECRUITING

Rozzano, Italy
Research Site
ACTIVE_NOT_RECRUITING

Bunkyō City, 113-8519, Japan
Research Site
ACTIVE_NOT_RECRUITING

Bunkyō City, Japan
Research Site
ACTIVE_NOT_RECRUITING

Fukuoka, Japan
Research Site
ACTIVE_NOT_RECRUITING

Hirosaki-shi, Japan
Research Site
ACTIVE_NOT_RECRUITING

Kanazawa, Japan
Research Site
ACTIVE_NOT_RECRUITING

Kawasaki, Japan
Research Site
ACTIVE_NOT_RECRUITING

Kōtoku, 135-8550, Japan
Research Site
ACTIVE_NOT_RECRUITING

Nagoya, Japan
Research Site
ACTIVE_NOT_RECRUITING

Niigata, Japan
Research Site
ACTIVE_NOT_RECRUITING

Okayama, 700-8558, Japan
Research Site
ACTIVE_NOT_RECRUITING

Sapporo, Japan
Research Site
ACTIVE_NOT_RECRUITING

Toyama, Japan
Research Site
RECRUITING

Ube-shi, 755-8505, Japan

Conditions

Explore the condition pages connected to this study.

BLADDER CANCER UROTHELIAL CANCER